How Shenzhen Reversed HIV Trends Among MSM Through Combined Prevention Strategy

What Sparked This Breakthrough in HIV Prevention?

Shenzhen's comprehensive HIV prevention strategy has successfully reversed a concerning upward trend in HIV infections among men who have sex with men (MSM), according to a landmark 13-year study published in BMC Infectious Diseases. The research documented a dramatic shift from a 14.7% annual increase in HIV yield between 2009-2012 to a 9.5% annual decrease between 2017-2021, following the implementation of a three-pronged intervention approach that combined venue-based behavioral interventions with pharmacological strategies.

The study tracked over 21,000 MSM in Shenzhen from 2009 to 2021, capturing data before and after the implementation of three key interventions: venue-based differentiated behavioral interventions (VBDB) beginning in 2012-2013, immediate combined antiretroviral treatment (cART) initiated in 2016, and pre-exposure/post-exposure prophylaxis (PrEP/PEP) promotion launched in 2019. This comprehensive longitudinal assessment provides valuable insights into the real-world effectiveness of layered HIV prevention strategies in a high-risk population. Shenzhen, a megacity with a young, mobile population where approximately 90% of MSM are internal migrants, has historically reported HIV prevalence rates exceeding the national average, making this decline particularly significant.

Which Strategy Turned the Tide?

The interrupted time series analysis revealed that the VBDB interventions produced the most substantial impact, causing an immediate downward shift in HIV yield. This approach involved collaboration between public health officials and venue operators to create tailored intervention packages based on venue characteristics and client profiles. The analysis showed that while immediate cART and PrEP/PEP promotion contributed to the continued downward trend, they did not independently demonstrate statistically significant effects beyond the VBDB interventions. Researchers attribute this to several factors, including late HIV diagnosis (approximately 35% of cases), low PrEP/PrEP utilization rates (8-10% among MSM in Shenzhen), and challenges with treatment adherence. The study also documented improvements in HIV testing rates and reductions in unprotected anal intercourse and drug use over the study period, though COVID-19 disruptions temporarily reversed some of these positive trends in 2020-2021.

What Do Local Experts Reveal?

Dr. Lin Lu, Director of the HIV Prevention Division at the Shenzhen Center for Disease Control and Prevention, emphasized the significance of these findings: "This study demonstrates that behavioral interventions remain critically important even in the era of pharmaceutical prevention. The combination of venue-based approaches with biomedical interventions created a synergistic effect that has meaningfully reduced HIV transmission in a challenging population." The research team noted that the city's HIV yield among MSM has fallen below the national average since 2018, contrasting with stable national rates around 8% despite the nationwide implementation of immediate cART in 2016. This divergence suggests the particular effectiveness of Shenzhen's venue-based approach.

How Did External Factors Influence Outcomes?

The findings arrive as public health systems worldwide reassess HIV prevention strategies in the wake of COVID-19 disruptions. During pandemic lockdowns, Shenzhen's CDC partnered with NGOs to launch an innovative online self-test kit distribution program, helping maintain HIV testing access despite restricted mobility. However, the study documented concerning trends during this period, including decreased HIV testing rates (from 82.6% in 2019 to 70.9% in 2021) and a significant rebound in multiple sexual partnerships following lockdown periods. These patterns highlight the vulnerability of prevention progress to external disruptions and the need for resilient, adaptable intervention strategies.

The joinpoint regression analysis provided additional insights into behavioral changes among the MSM population over the study period. The prevalence of unprotected anal intercourse decreased significantly at a rate of 0.92% every six months, while HIV testing increased significantly from 2009 to 2020 before declining during the COVID-19 pandemic. The prevalence of men who have sex with men and women (MSMW) decreased significantly throughout the study period, reflecting changing sexual behavior patterns in this community. Notably, the prevalence of multiple anal sexual partners decreased significantly from 2009 to 2018 but then increased significantly from 2018 to 2021, with a pronounced rebound following COVID-19 lockdowns, suggesting potential risk compensation effects.

The multilevel regression analysis comparing three time periods (2009-2012, 2013-2016, and 2017-2021) revealed important transitions in risk profiles. Compared to the pre-intervention period, MSM in the 2013-2016 period showed higher odds of HIV infection and sexually transmitted infections (STIs), but were more likely to have been tested for HIV. In contrast, MSM in the 2017-2021 period showed significantly lower odds of HIV infection compared to the baseline period, despite still having elevated STI rates, suggesting a potential decoupling of HIV and other STI transmission risks as interventions took effect.

What Are the Global Implications for HIV Prevention?

The research has significant implications for HIV prevention program design globally, particularly in regions with concentrated epidemics among MSM populations. It underscores that while pharmaceutical interventions like PrEP and immediate treatment are essential components of prevention, behavioral approaches tailored to local contexts remain crucial for maximizing impact. The study authors recommend continued investment in combined strategies, with particular attention to addressing challenges in late diagnosis, treatment adherence, and the shifting social dynamics of MSM communities as interaction increasingly moves from physical venues to online platforms.

How Does the Industry View These Findings?

Industry Context: This research emerges amid a broader shift in HIV prevention toward precision approaches that combine behavioral and biomedical interventions. While pharmaceutical companies have heavily invested in antiretroviral therapies and PrEP formulations, this study suggests the effectiveness of these interventions depends significantly on behavioral and structural factors specific to target populations. The findings support a comprehensive market approach where diagnostic companies, digital health platforms, and community-based organizations play crucial roles alongside pharmaceutical interventions. As resource allocation decisions become increasingly evidence-driven, studies demonstrating real-world effectiveness of combined approaches may influence both public health spending and private investment in the HIV prevention space.

What Do the Numbers Tell Us About the Epidemic?

The study methodology employed a robust analytical framework, combining joinpoint regression with interrupted time series analysis to isolate the effects of each intervention phase. Researchers calculated the semiannual percentage change (SPC) to quantify shifts in HIV yield trends, revealing statistically significant changes corresponding to intervention implementation timepoints. The HIV yield among MSM increased at a mean rate of 14.70% (SPC=14.70%, 95% CI 5.00–25.30%) from 2009 to 2012 in the pre-intervention period, then decreased at a mean rate of 3.80% (SPC=-3.80%, 95% CI -7.10–-0.40%) from 2013 to 2016 during VBDB interventions, and declined more rapidly at 9.50% (SPC=-9.50%, 95% CI -12.80–-6.20%) from 2017 to 2021 with the addition of immediate cART and PEP/PrEP promotion.

The study also captured important demographic and behavioral characteristics of the MSM population in Shenzhen. The average age of participants was 30.45±7.60 years, with 38.20% reporting unprotected anal intercourse (UAI), 31.43% classified as men who have sex with men and women (MSMW), 1.95% reporting drug abuse, 12.85% having multiple anal sexual partners, 10.44% diagnosed with sexually transmitted infections (STIs), and 29.49% never having been tested for HIV. These baseline characteristics helped researchers identify risk factors and target intervention strategies more effectively.

Molecular surveillance data provided additional supporting evidence for the effectiveness of the interventions. According to previously published research on HIV molecular networks in Shenzhen, the clustering rate in molecular networks of each HIV-1 subtype among MSM decreased from 2011 to 2018, suggesting reduced transmission chains and supporting the epidemiological findings of declining HIV yield. This molecular evidence strengthens the case that the observed reductions represent true declines in transmission rather than artifacts of sampling or testing patterns.

The study authors acknowledged several limitations in their approach. The sampling methodology, while consistent across survey rounds, may not fully represent all MSM subgroups, particularly those who are less sexually active or more socially hidden. Additionally, the ecological study design makes it challenging to establish definitive causal relationships between specific interventions and observed changes in HIV yield. The findings are also specific to Shenzhen's unique demographic context as China's largest migrant city with a younger population structure than other regions, potentially limiting generalizability.

What Are the Prospects for Future HIV Prevention?

Despite these limitations, the study provides compelling evidence for the effectiveness of combined behavioral and pharmaceutical interventions in reducing HIV transmission among MSM. The researchers emphasized that the study results should be interpreted within the broader context of changing social dynamics in the MSM community, particularly the shift from venue-based socialization to online dating platforms, which may have influenced intervention effectiveness over time.

Public health experts have noted that Shenzhen's experience offers valuable lessons for other high-prevalence regions. The VBDB intervention model, with its emphasis on venue-operator partnerships and environmental modifications, represents an innovative approach that could be adapted to other urban settings with established MSM venue networks. However, as social interaction patterns continue to evolve toward digital platforms, future interventions will likely need to incorporate online outreach strategies to maintain effectiveness.

The study results come at a critical juncture for HIV prevention globally. As health systems recover from COVID-19 disruptions and reassess prevention priorities, evidence supporting combination approaches that integrate behavioral and pharmaceutical strategies is particularly valuable. The Shenzhen experience demonstrates that even in settings with high HIV prevalence among MSM, comprehensive and sustained interventions can reverse epidemic trends.

For pharmaceutical stakeholders and public health funders, the findings underscore the importance of considering local implementation contexts when developing HIV prevention programs. The study suggests that the effectiveness of biomedical interventions like PrEP and immediate treatment depends significantly on complementary behavioral strategies and healthcare delivery systems that facilitate diagnosis, linkage to care, and treatment adherence.

The research team concluded that while significant progress has been made in reducing HIV transmission among MSM in Shenzhen, sustained effort will be required to maintain and extend these gains. They recommended continued investment in combined intervention strategies, with particular attention to addressing emerging challenges such as the shift to online socialization, potential risk compensation behaviors, and the need for resilient service delivery models that can withstand disruptions like those experienced during the COVID-19 pandemic.

Summary

A landmark 13-year study published in BMC Infectious Diseases reveals that Shenzhen successfully reversed HIV infection trends among men who have sex with men through a comprehensive three-pronged prevention strategy. The research documented a dramatic shift from a 14.7% annual increase in HIV yield between 2009-2012 to a 9.5% annual decrease between 2017-2021, tracking over 21,000 MSM participants. The study found that venue-based differentiated behavioral interventions, implemented in 2012-2013, produced the most substantial impact, with immediate combined antiretroviral treatment and pre-exposure/post-exposure prophylaxis providing additional support. Interrupted time series analysis revealed that behavioral interventions remained critically important even alongside pharmaceutical prevention methods, with the combination creating a synergistic effect that reduced transmission in this high-risk population. The findings are particularly significant given that Shenzhen is a megacity where approximately 90% of MSM are internal migrants and historically reported HIV prevalence rates exceeding the national average. However, the COVID-19 pandemic temporarily disrupted progress, with decreased HIV testing rates and a rebound in multiple sexual partnerships following lockdowns. The research provides valuable insights for global HIV prevention program design, demonstrating that pharmaceutical interventions like PrEP and immediate treatment require complementary behavioral approaches tailored to local contexts for maximum effectiveness. The study emphasizes the importance of resilient, adaptable intervention strategies that can address emerging challenges such as the shift from physical venues to online platforms for social interaction among MSM communities.